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LysisMaximin H5 is an anionic antimicrobial peptide from amphibians, which carries a C-terminal amide moiety, and
was found to be moderately haemolytic (20%). The α-helicity of the peptide was 42% in the presence of lipid
mimics of erythrocyte membranes and was found able to penetrate (10.8 mN m−1) and lyse these model
membranes (64 %). In contrast, the deaminated peptide exhibited lower levels of haemolysis (12%) and α-
helicity (16%) along with a reduced ability to penetrate (7.8 mN m−1) and lyse (55%) lipid mimics of
erythrocyte membranes. Taken with molecular dynamic simulations and theoretical analysis, these data suggest
that native maximin H5 primarily exerts its haemolytic action via the formation of an oblique orientated
α-helical structure and tiltedmembrane insertion. However, the C-terminal deamination ofmaximin H5 induces
a loss of tiltedα-helical structure, which abolishes the ability of the peptide's N-terminal and C-terminal regions
to H-bond and leads to a loss in haemolytic ability. Taken in combination, these observations strongly suggest
that the C-terminal amide moiety carried by maximin H5 is required to stabilise the adoption of membrane
interactive tilted structure by the peptide. Consistent with previous reports, these data show that the efﬁcacy
of interaction and speciﬁcity of maximin H5 for membranes can be attenuated by sequence modiﬁcation and
may assist in the development of variants of the peptide with the potential to serve as anti-infectives.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
Antimicrobial peptides (AMPs) are ancient components of the
innate immune systems that are found in creatures from across
the eukaryotic kingdom and they possess potent activity against a
wide spectrum of bacteria, viruses, fungi and parasites [1,2]. In general,
this activity involvesmembrane interaction [3,4] and increasingly, it has
been found that post-translational modiﬁcations (PTMs) play a role in
optimising the efﬁcacy and speciﬁcity of these mechanisms of action
[5–9]. Most of the PTMs identiﬁed in AMPs are relatively infrequent in
occurrence [6], typically the phosphorylation of residues [1,6,10] and
the chiral inversion of residues to produce D-amino acids [11–13].
However, two PTMs have been found to be ubiquitous amongst AMPs
of eukaryotes [6] of which the ﬁrst is the oxidation of cysteine residuess;CD,circulardichroism;DMPC,
mic; PTMs, post-translational
ity, 103 Borough Road, London
6099.to form disulphide bridges [14]. It is generally accepted that disulphide
bridges play a major architectural role in the antimicrobial action of
AMPs [6], primarily by maintaining the amphiphilic topography of the
molecules and thereby their ability to interact with target membranes
and kill host cells [5,15]. This form of structural stabilisation is also
important for the therapeutic development of AMPs as seen with the
cysteine knot architectures of cyclotides from plants [2,16]. The
exceptional stability of these peptides coupled to their high tolerance
of residue substitutions [17] makes them potential candidates to
serve as lead compounds in scenarios ranging from tumour imaging
[18] to preventing the sexual transmission of HIV [19].
The secondmost common PTM found in AMPs is the introduction of
C-terminal moieties, which have predominantly been identiﬁed in
amphibians [6]. These fall into twomajor classes: the presence of either
a Ranabox [20] or an amide group [21]. The Rana box is found in the vast
majority of Ranid frogs and consists of a C-terminal cyclic heptapeptide
with a conserved disulphide bond [20,22,23]. This PTM occurs in AMPs
such as gaegurins and palustrins and appears to play a role in facilitating
the membrane afﬁnity of these peptides by stabilising their C-terminal
structure [20,24]. In contrast, the importance of C-terminal amidation
in the antimicrobial action of amphibian and other AMPs is far from
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maximinH1 tomaximinH55,were identiﬁed in toads from theBombina
genus. These AMPs all exhibited C-terminal amidation, clearly suggest-
ing functional relevance [26–28]. Studies on synthetic AMPs have
shown that C-terminal amidation can enhance antibacterial efﬁcacy
without increasing lytic ability thereby increasing the therapeutic
potential of these peptides [29]. Given that maximin H5 from Bombina
maxima has potent, narrow range, antibacterial activity [30], we have
investigated the role of C-terminal amidation in the interactions of the
peptide with erythrocyte membranes to help elucidate the suitability
of the peptide for medical use.2. Materials and methods
2.1. Reagents
A synthetic homologue of maximin H5, MH5N (ILGPVLGLVSD
TLDDVLGIL-CONH2), and its C-terminally deamidated isoform, MH5C
(ILGPVLGLVSDTLDDVLGIL-COOH), were manufactured by Pepceuticals
(Leicestershire, UK) by solid state synthesis and puriﬁed by HPLC to pu-
rity greater than 95%. Dimyristoyl phosphatidylcholine (DMPC) was
supplied by Avanti Polar Lipids (Alabaster, Alabama) and used without
further puriﬁcation and analysed using mass spectrometry (Fig. S1).
All other reagents were supplied by SIGMA (UK) and VWR (UK) unless
otherwise stated.2.2. The antibacterial assay of maximin H5 isoforms
Cultures of Escherichia coli, strainW3110, and Staphylococcus aureus,
strain UL12, which had both been freeze-dried in 20% (v/v) glycerol and
stored at −80 °C, were used to inoculate 10 ml aliquots of sterile
nutrient broth and incubated at 37 °C until the exponential phase was
reached (OD = 0.6; λ= 600 nm). The cell cultures were then centri-
fuged at 15,000 ×g at 4 °C for 15 min using a bench top centrifuge.
The resulting pellet was washed three times in 25% strength Ringer's
solution and then re-suspended in 1 ml Ringer's solution. 1 ml aliquots
of maximin H5 isoforms ranging from 0 μM to 1000 μMwere prepared
separately in 25% strength Ringer's solution by the double dilution
method. 20 μl of each test bacterial suspension was added to separate
1ml aliquots of peptide and incubated at 37 °C for 48h. After incubation,
each bacterial culture was streaked onto nutrient agar plates so as to
create a six-spoked star wheel and incubated at 37 °C for 12 h as previ-
ously described by Dennison et al. [31]. This method was carried out in
triplicate. The minimum inhibition concentration (MIC) was
determined from the lowest ﬁnal concentration of peptide at which
nogrowthwas observed during the predetermined period of incubation
in any of the triplicate samples.2.3. The haemolytic ability of maximin H5 isoforms
The haemolytic activity of MH5N and MH5C were investigated
using fresh human red blood cells (3 ml), which were washed 3
times with phosphate buffered saline (PBS, pH 7.4) by centrifugation
for 5 min at 1200 ×g until the supernatant was clear. Washed red
blood cells were resuspended in PBS to a ﬁnal volume of 20 ml.
Peptide solutions (10 μl) were added to a 190 μl suspension of
washed red blood cells and incubated for 1 h at 37 °C. The samples
were then centrifuged at 12,000 ×g for 5 min. The release of
haemoglobin was monitored by diluting 100 μl of supernatant with
900 μl PBS and measuring the absorbance at 576 nm [APeptide].
For negative and positive controls, PBS buffer [APBS] and 0.1% Triton
X-100 [ATriton] were used. These experiments were performed in
quadruplicate and the mean percentage haemolysis calculatedusing the equation [32,33]:
Pecentagehaemolysis ¼
APeptide
h i
− APBS½ 
ATriton½ − APBS½ 
 100:
2.4. Secondary structural analysis of maximin H5 isoforms
Secondary structure analysis of MH5N and MH5C was performed
using a J-815 spectropolarimeter (Jasco, UK) at 20 °C, as previously
described [34]. Samples were prepared by dissolving the peptides in
phosphate buffered saline (PBS) and 2,2,2-triﬂuoroethanol/phosphate
buffered saline (TFE/PBS; 50% v/v) to give a ﬁnal peptide concentration
of 60 μM in each case. Circular dichroism (CD) structural analysis was
also performed with MH5N and MH5C in the presence of lipid. DMPC
(19 mg ml−1) was dissolved in chloroform, dried under N2 gas before
being vacuum-dried, and the resulting lipid ﬁlm rehydrated using
1 × PBS (pH 7.5) for an hour, or until the solution was no longer turbid.
These samples were then freeze-thawed 4 times, followed by extrusion
11 times with a 0.1 μm polycarbonate ﬁlter using an Avanti Polar
Lipids mini-extruder apparatus. Peptide/lipid samples were prepared
by adding stock peptide solution to a measured volume of lipid suspen-
sion to obtain the desired peptide:lipid molar ratio (1:100) before
being mixed thoroughly. Far UV (180 to 260 nm) CD spectra were re-
corded using 0.5 nm intervals, a bandwidth of 1 nm, a scan speed of
100 nm min−1 and a 10 mm path-length cell. Four scans per sample
were performed and averaged. For secondary structure estimation, the
CD spectrawere deconvoluted using the CDSSTR algorithm (protein ref-
erence set 3) on the DichroWeb server [35–37].
2.5. Lipid monolayer analysis of maximin H5 isoforms
Lipid monolayers of DMPC were formed by dropping chloroformic
solutions of the lipid onto a Tris buffer subphase (10 mM; pH 7.5)
contained in an 80 ml 601 M Langmuir Teﬂon trough (Biolin Scientif-
ic/KSVNIMA, UK). Surface pressure (π)wasmeasured using aWilhelmy
wire attached to a microbalance. After spreading, the solvent was
allowed to evaporate off the subphase surface over 30 min and the
barriers were closed at a rate of 5 cm2 min−1 until a starting pressure
of 30 mN m−1 was achieved, which is equivalent to that of the outer
leaﬂet of a cell membrane [38]. Monolayers were allowed to equilibrate
for a further 30 min before MH5N and MH5C were injected into the
subphase using an L-shaped Hamilton syringe without disruption of
the monolayer.
2.6. The lytic ability of maximin H5 isoforms
DMPC (7.5 mg) was dissolved in chloroform and dried under N2 gas
before being vacuum-dried. The resulting lipid ﬁlm was then hydrated
with 1 ml of HEPES (5.0 mM; pH 7.5) containing calcein (70 mM). The
suspension was vortexed for 5 min and then sonicated for 30 min
after which, the solution underwent 3 cycles of freeze-thawing. Lipo-
somes were extruded 11 times through a 0.1 μm polycarbonate ﬁlter
using an Avanti polar lipidsmini-extruder apparatus. Calcein entrapped
vesicles were separated from free calcein by gel ﬁltration using a
Sephadex G75 column (SigmaAldrich, UK)whichwas rehydrated over-
night in HEPES (20 mM; pH 7.5), NaCl (150 mM) and EDTA (1.0 mM).
The column was then eluted with HEPES (5 mM; pH 7.5).
The calcein release assay was performed by combining 2 ml of
HEPES (20 mM; pH 7.5), NaCl (150 mM) and EDTA (1.0 mM) with
20 μl of calcein vesicles. MH5N and MH5C (90 μM) were incubated
with these vesicles and the ﬂuorescence intensities of released calcein
measured using an FP-6500 spectroﬂuorometer (Jasco, UK), with an ex-
citation wavelength of 490 nm and emission wavelength of 520 nm.
Membrane lysis of 100% was taken as the ﬂuorescence induced by
Fig. 1. The haemolytic ability of isoforms of maximin H5. The ﬁgure shows the haemolytic
activity ofMH5N (black) andMH5C (grey) towards human red blood cells. MH5N showed
greater activity towards these cells thanMH5Cwith these peptides inducing 20% and 12%
lysis, respectively, at 90 μM, which is the reported antibacterial minimum inhibitory con-
centration (MIC) for maximin H5 [28,39]. These experiments were performed in quadru-
plicate and error bars represent the standard deviation.
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lysis achieved by MH5N and MH5C was then calculated relative to this
standard.
2.7. MD simulations of maximin H5 isoforms
The conformational behaviour and lipid interactivity of MH5N and
MH5C in the presence of DMPC membranes was examined by molecu-
lar dynamics calculations, as previously described [39]. Using peptide/
lipid ratios of 3:128,models forMH5NandMH5Cwere assembled as ca-
nonical α-helices using AMBER tools 12 as previously described [39].
Simulations and analysis were performed using GROMACS and the
GROMOS96 53a6 force ﬁeld was used with the step descendedmethod.
Bilayer parameters were used from references and the simple point-
charge (SPC) water model was used in all simulations. All structures
were equilibrated at room temperature in water in the sequence: min-
imization, NVT andNPT simulations. The simulations inwaterwere per-
formed by solvating the peptide in a box: 6 nm × 6 nm × 6 nm with
approximately 8000 water molecules. Counter-ions (Na+, Cl−) were
added to the system to make it neutral. The peptide was simulated
with backbone atoms restrained in NVT and then NPT ensemble with
pressure maintained at 1 atm by isotropic coupling to a Berendsen
barostat and the temperaturemaintained at 303 K. A freemolecular dy-
namic simulation of 200 nswithout restraintwas performed at constant
temperature, pressure and number of molecules (NPT ensemble). The
membrane was simulated using a DMPC bilayer containing 128 lipidFig. 2. CD structural analysis of maximin H5 isoforms in solvent systems. The ﬁgure shows CD
(black) and DMPC (dotted black). Analysis of these spectra indicated that in PBS, both peptide
characteristic of random coil and β-sheet structure. For both MH5C and MH5N, their α-helica
v), both peptides displayed a curve characterised by a double minimum at 205 and 225 nm,
MH5N possessedα-helical contents of N60% with the remaining structural contributions to the
data, Table 1). Similarly, in the presence of DMPC, analysis of these spectra showed that α-helimolecules in a box 7 nm × 7 nm × 9.0 nm (xyz box) with the bilayer
normal being parallel to the z-axis. An equilibration run was 400 ns
long at 303 K in a box containing circa 10,000 water molecules. For
both MH5N and MH5C, three peptide molecules were inserted into
the box containing the solvated bilayer. An equilibration run of 2 ns
was carried out for the peptide-bilayer system with the position of the
peptides restrained using harmonic restrains with constant force of
1.0 kJ−1 nm−2 per atom. The cut off for both vanderWaals and Coulom-
bic interactions was 1.2 nm. Berendsen temperature coupling was used
at 303 K and thewater and the bilayer were coupled separately. A semi-
isotropic Berendsen barometerwas used. Themainmolecular dynamics
simulation (no restraints) runs were performed at constant tempera-
ture, pressure and number of molecules.
3. Results
3.1. The antibacterial assay of maximin H5 isoforms
The antimicrobial activity ofMH5Nwas tested and exhibited activity
against S. aureus (MIC= 90 μM) but was found to be ineffective against
E. coli, which is consistent with previous reports [30]. In contrast, MH5C
was found to have a reduced capability to inactivate S. aureus (MIC =
180 μM) but was effective against E. coli (MIC = 180 μM). The antibac-
terial activity of both peptides is comparable with that of other anionic
AMPs [1,16] such as Cn-AMP2 and Cn-AMP3 from the plant, Cocos
nucifera [40], and GH-1L, and GH-1D, from the toad, Bombina orientalis
[41].
3.2. The haemolytic ability of maximin H5 isoforms
The ability of MH5N andMH5C to interact with human erythrocytes
was assayed and it was found that below concentrations of 25 μM, both
peptides showed low, comparable haemolytic activity, whichwas b12%.
Above 25 μM, MH5N became progressively more haemolytic than
MH5C although both peptides remained moderately active towards
erythrocytes, inducing between circa 15% and 25% lysis at peptide con-
centrations above 450 μM (Fig. 1). These data also showed that at its
MIC for S. aureus (90 μM) MH5N exhibited haemolysis levels of 20%
whilst at its MIC for both S. aureus and E. coli (180 μM) MH5C induced
haemolysis levels of 12%.
3.3. Secondary structural analysis of maximin H5 isoforms
The conformational behaviour ofMH5N andMH5C in different envi-
ronments was investigated using CD spectroscopy. In aqueous solution,
both peptides were not well folded with a maximum at 212 nm and aspectra for MH5N (A) and MH5C (B) in the presence of PBS (grey); TFE/water (50% v/v)
s were not well folded with a maximum at 212 nm and a minimum at 195 nm, which is
l content was b10% (Supplementary data, Table 1). In the presence of TFE/water (50% v/
which is typical of α-helical peptides. Analysis of these spectra showed that MH5C and
ir molecular architecture coming from random coil and β-type structures (Supplementary
cal contributions to the structures of MH5N and MH5C were 42% and 16% respectively.
Fig. 3. The interaction of maximin H5 isoforms with lipid monolayers. The ﬁgure shows
the interaction of MH5N (black) and MH5C (grey) with monolayers formed from DMPC.
MH5N showed a greater ability to partition into these monolayers than MH5C with
these peptides inducing maximal surface pressure changes of 10.8 mN m−1 and
7.8 mN m−1, respectively.
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MH5N and MH5C both possessed b10% α-helical structure and were
predominantly formed from random coil and β-type structures (Sup-
plementary data, Table 1). A key step in the membrane interaction of
AMPs involves the adoption of secondary structures in the anisotropic
environment of the interface [29], which is often investigated using
TFE, a lipophilic, membrane-mimicking solvent [42]. Fig. 2 shows that
in a TFE/water mixture (50% v/v), both MH5N and MH5C display a
curve, which is characterised by a double minimum at 205 and
225 nm and typical of α-helical peptides. Further analysis of these CD
spectra showed that both peptides were N60% α-helical with theFig. 4.MD simulations of the membrane interaction of maximin H5 isoforms. The ﬁgure show
DMPC. In these simulations, three molecules of each peptide were initially orientated parallel
formed an aggregate and partitioned into the membrane. Each aggregate showed a series of
only very minor changes in this structure up to 400 ns (A). Snapshots of the aggregates forme
deeply than MH5C (A and B). These ﬁgures also showed that the aggregates formed by MH5
bonds (speciﬁc examples shown in Figs. 6 and 7). MH5C formed no hydrogen bonds with DMPC
ciﬁc examples shown in Fig. 6). However, the C-terminal amide moiety of MH5N appeared toremaining structural contributions to these peptides coming from ran-
dom coil and β-type architectures (Supplementary data, Table 1). The
outer leaﬂets of erythrocyte plasma membranes are composed mainly
of choline lipids, predominantly phosphatidylcholine (PC), which was
used in the present study as a lipid model for erythrocyte membranes
[43]. The conformational preferences of MH5N and MH5C in the pres-
ence of DMPCwere investigated: the resulting spectra for both peptides
showed negative bands around 222 and 210 nm, indicative of the pres-
ence ofα-helical structure (Fig. 2). Analysis of these CD spectra showed
that the α-helical contributions to the structure of MH5N were 42%
whilst those for MH5Cwere 16%. For both peptides, the remaining con-
tributions to theirmolecular architecture came from random coil andβ-
type structures (Supplementary data, Table 1).3.4. Lipid monolayer analysis and the lytic ability of maximin H5 isoforms
The interaction ofmaximinH5 isoformswithmembraneswas inves-
tigated using monolayers formed from DMPC. Both peptides interacted
rapidly with these monolayers, inducing maximal surface pressure
changes of 7.8 mNm−1 and 10.8mNm−1 for MH5C andMH5N respec-
tively (Fig. 3). These surface pressure changes indicate high levels of
lipid interaction, which are consistent with disruption of themonolayer
acyl chain region by maximin H5 and imply a major role for hydropho-
bic forces in driving the membrane interactions of the peptide. The in-
teraction of maximin H5 isoforms with membranes was further
investigated using large unilamellar vesicles (LUVs) formed from
DMPC and containing calcein. Both peptides were found to possess
membranolytic ability that paralleled their interactions with lipid
monolayers: MH5N and MH5C induced 64% and 55% lysis of these
LUVs respectively.s MD simulations for the interaction of MH5C and MH5N with membranes formed from
to the bilayer and upon interaction with the bilayer surface, each group of three peptides
changes in its overall levels of secondary structure up to 200 ns but thereafter showed
d by these peptides after 400 ns showed that MH5N penetrated DMPC membranes more
N and MH5C respectively were stabilised by intra-peptide and inter peptide hydrogen
lipids (C) but in contrast, MH5N formedmultiple hydrogen bonds with these lipids (spe-
form no hydrogen bonds with DMPC lipids.
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Molecular dynamic (MD) simulations were used tomodel and char-
acterise the interaction of MH5C and MH5N with membranes formed
from DMPC to provide insight into the mechanism of membrane
partitioning utilised by maximin H5 (Figs. 4–6). In these simulations,
three molecules of each peptide were initially orientated parallel to
the bilayer and in each case, after 20 ns, these three molecules
interacted with each other prior to interaction at the bilayer surface.
Upon interaction with the bilayer surface, each group of three peptides
formed an aggregate. This showed a series of changes in its overall levels
of secondary structure up to 200 ns but thereafter showed only very
minor changes in this structure up to 400 ns (Fig. 4A). Analysis of snap-
shots of the aggregates formed by MH5C and MH5N after 400 ns
(Fig. 4A, B and C) predicted that the secondary structure elements
adopted by these peptides in the presence of DMPC (Fig. 5A and
B)were generally consistentwith those determined by CD spectroscopy
(Supplementary material Table 1). In the case of MH5N, two peptides
were predicted to predominantly form unfolded, or β-type structures,
but the third was predicted to possess overall levels of α-helicity of
circa 40%. This α-helical structure was localised within an N-terminal
segment comprising residues I1–S10 of the peptide, and a short C-
terminal region comprising residues V16–L(NH2)20 (Fig. 4A and B). In
the case of MH5C, two peptidemolecules were also predicted to mainlyFig. 5.MD predictions for the secondary structures of maximin H5 isoforms. Panels A and B sh
MH5N andMH5C showed levels ofα-helicity that were circa 40% and 15% (in blue), respectivel
proﬁles were also generated by theseMD simulations (C and D) and the graphic in each panel s
sity (solid black line), lipid head-groups (dots), lipid tails groups (dashed line) and peptide (pu
etrate the hydrophobic membrane core region of DMPC membranes more deeply than MH5Cform unfolded, or β-type structures, but in contrast to MH5N, the third
peptide of MH5C was predicted to possess levels of α-helical structure
that accounted for only circa 15% of the peptide's overall structure.
This α-helical structure predominantly lay in an N-terminal segment,
residues I1–V5, and a C-terminal region, residues V16–L20 (Fig. 5A
and B).
Partial density proﬁles were derived from MD simulations and
predicted that aggregates of MH5C and MH5N respectively (Fig. 5C
and D) would penetrate the hydrophobic core region of DMPC mem-
branes. However, aggregates of MH5N (Fig. 5C) showed deeper
levels of membrane penetration levels than those of the MH5C
(Fig. 5D). Snapshots of the aggregates formed by MH5C and MH5N
after 400 ns were further analysed and showed that the penetration
of DMPC membranes by these aggregates involved a variety of intra-
peptide, inter-peptide and peptide–lipid hydrogen bonds although
via clearly different mechanisms (Figs. 4–6). A major difference be-
tween these mechanisms was that MH5C showed no peptide–lipid
hydrogen bonds in its interaction with DMPC membranes whereas
MH5N formed multiple hydrogen bonds with lipid head-groups
(Fig. 6). For example, the L8 residue of one unfolded MH5N peptide
formed a hydrogen bond with the phosphate group of a DMPC lipid
whilst the I1 residue of the second unfolded MH5N peptide formed
hydrogen bonds with the phosphate group of another two DMPC
lipids (Fig. 6). The L(NH2)20 groups of all three MH5N peptides layow the secondary structure elements predicted for MH5N and MH5C by MD simulations.
y, which is generally consistent with those determined by CD spectroscopy. Partial density
hows partial densities of the components in these peptide–lipid systems: overall lipid den-
rple line). Essentially, these partial density proﬁles predicted that MH5N (C) would pen-
(D).
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DMPC lipids (Figs. 4 and 5).
A second major difference between the interaction of MH5C and
MH5N with DMPC membranes lay in the role of the α-helical peptide
present in the aggregates of both peptides. Snapshots of the aggregates
formed by MH5N after 400 ns showed that its α-helical peptide pene-
trated the bilayer at an angle of circa 45° in a hairpin-type structure
(Fig. 4A and B). One arm of this structure was formed by the N-
terminal residues, I1–S10, in a strongly α-helical conformation, whilst
the other arm comprised a disordered region, which was terminated
by a short α-helical segment at the C-terminus of the peptide formed
by residues L16–L(NH2)20. This oblique orientation of MH5N was
stabilised by hydrogen bonds between residues in the two α-helical
regions of the peptide and phosphate groups in the lipid's head-group
region (Fig. 4A and B). Complementing these peptide–lipid interactions
was an intra-peptide hydrogen bond between the C-terminal residue,
L(NH2)20, of MH5N and its N-terminal residue, I1 (Fig. 7). The corre-
sponding snapshots of MH5C showed that the peptide penetrated
DMPC membranes in an orientation and structural conformation that
resembled that observed for MH5N (Fig. 4A and C). However, in con-
trast to MH5N, the α-helical arm of the MH5C hairpin was truncated
and comprised residues, I1–V5, with the result that the disordered re-
gion of the juxtaposed arm was elongated before termination by a
C-terminal, α-helical segment formed by residues V16–L20. This
oblique orientation of MH5C was primarily stabilised by hydrogen
bonds between residues in the two α-helical regions of the peptide
and phosphate groups in the lipid's head-group region (Fig. 4A and C).
However, in further contrast to MH5N, L20 of MH5C was found to be
distal from the N-terminal residue, I1, of the peptide with no evidence
of hydrogen bonding between these two residues (Fig. 7).
4. Discussion
Maximin H5 is an anionic antibacterial peptide recently identiﬁed in
the brains and skin secretions of the Australian toad, B. maxima and itFig. 6. The peptide–peptide and peptide–lipid interactions of maximin H5 isoforms. Aggregates
drogen bonds (A–E). As examples, the V16 residue of one unfolded peptide formed a hydrogen b
the I1 residue of one unfolded peptide hydrogen bonded to the I1 residue of the other unfold
(Fig. 4C) but in contrast, MH5N formed multiple hydrogen bonds with these lipids (C–E). Fo
bonds with the phosphate group of two DMPC lipids (C). The other unfolded peptide in these a
(D) and its S10 residue (E).has a narrow spectrum of antimicrobial activity having been reported
to kill only S. aureus [26,27,30]. These observations givemaximinH5po-
tential interest as a drug for development in the ﬁght against
methicillin-resistant S. aureus (MRSA),which is currently amajor global
cause of nosocomial and other infections [44]. However, for successful
therapeutic application, the toxicity of the peptide towards human
cells must be characterised and currently, no major investigations into
this area appear to have been undertaken. Accordingly, here, we have
investigated the activity of maximin H5 against bacteria and human
erythrocytes and determined the role of C-terminal amidation in this
activity.
Native maximin H5 showed no action against E. coli, conﬁrming
previous reports [30]. However, when modiﬁed by C-terminal
deamination, the peptide exhibited activity against this organism
(MIC = 180 μM). This result clearly demonstrates that the resistance
of E. coli to the action of maximin H5 depends upon the presence of
the peptide's C-terminal amide moiety and strongly supports recent
work [39]. Using MD simulations, these latter authors predicted that
H-bonding between the C-terminal amide group of maximin H5 and a
lipid receptor in E. coli membranes helped immobilise the peptide on
the membrane surface, thereby effectively rendering the organism re-
sistant to the action ofmaximinH5 [39]. C-terminally deaminatedmaxi-
min H5 differs from the native peptide in its ability to inactivate
S. aureus, exhibiting reduced toxicity towards the organism (MIC =
180 μM) as compared to that ofmaximinH5 (MIC of 90 μM). This clearly
suggests that the peptide's C-terminal amide group is required for efﬁ-
cient activity against the organism. Indeed, given that this C-terminal
amide group, along with its N-terminal counterpart, are the only posi-
tively charged moieties possessed by maximin H5, a likely role for
both these amide groups might be to assist in targeting anionic compo-
nents of the membranes possessed by S. aureus [30]. A similar targeting
function would seem ascribable to the C-terminal amide moiety pos-
sessed by a number of isoforms of the peptide, which also lack cationic
residues and have been identiﬁed as potent antibacterial agents that
function in the brain of B. maxima [26]. It is perhaps worthy of noteof both MH5C and MH5Nwere found to form intra-peptide (Fig. 7) and inter peptide hy-
ondwith G18 of the other unfolded peptide inMH5C aggregates (A). In the case ofMH5N,
ed peptide in these aggregates (B). MH5C formed no hydrogen bonds with DMPC lipids
r example, the I1 residue of an unfolded peptide in MH5N aggregates formed hydrogen
ggregates hydrogen bonded to the phosphate group of two DMPC lipids via its L8 residue
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noceptive function [26], suggesting that maximin H5 and its isoforms
may serve as neuropeptides and it is well established that C-terminal
amidation is essential for the function of many of these neuronal signal-
ling molecules [45].
Native maximin H5 was found to possess moderate haemolytic
activity (generally below 25%; Fig. 1) that was reduced by up to 12%
on C-terminal deamination of the peptide (Fig. 1). Reinforcing these
results, native maximin H5 induced dye release of 64% from DMPC
vesicles, which were taken as model erythrocyte membranes, however,
dye release by the peptide was decreased to 55% in the case of the
C-terminally deaminated peptide. In combination, these results clearly
suggest a role for the C-terminal amide group of maximin H5 in the
mechanism facilitating the peptide's haemolytic activity. Investigation
into the mechanism underpinning the haemolytic activity of native
maximin H5 suggested that the peptide was able to self-associate and
penetrate erythrocyte membranes via the formation of an aggregate
structure (Fig. 4A and B). This aggregate associated with the membrane
via a variety of peptide–lipid hydrogen bonding interactions, which,
however, did not involve the C-terminal amide, L(NH2), groups of the
contributing maximin H5 peptides (Figs. 4B and 7A). Two of the pep-
tides forming these aggregates were unfolded and appeared to play a
minor role in the membrane interactions of native maximin H5 by
stabilising the bilayer penetration of the remaining peptide contributing
to the aggregate (Fig. 4A and B). The latter peptide appeared to beFig. 7. C-terminal intra-peptide hydrogen bonding by maximin H5 isoforms. Panels A and
B showMD predictions for the secondary structure of MH5N andMH5Cwhen interacting
with DMPC membranes, which for clarity are shown in panels C and D with the lipids re-
moved. These simulations predicted that MH5N would penetrate these membranes at an
angle of circa 45° in a hairpin-type structure (A). One arm of this structure was formed by
theN-terminal residues, I1–S10, in a stronglyα-helical conformation,whilst the other arm
comprised a disordered region, whichwas terminated by a shortα-helical segment at the
C-terminus of the peptide formed by residue L16–L(NH2)20. This overall conformation of
MH5Nwas stabilised by a hydrogen bond4 between its C-terminal residue, L(NH2)20, and
its N-terminal residue, I1 (4.5 Å, C). Correspondingmodelling forMH5C predicted that the
peptidewould penetrate the bilayer in an orientation and structural conformation that re-
sembled that observed for MH5N (B). However, in contrast to MH5N, theα-helical arm of
the MH5C hairpin was truncated and comprised residues, L1–V5, with the result that the
disordered region of the juxtaposed arm was elongated before termination by a C-termi-
nal,α-helical segment formed by residueV16–L20 (D). In further contrast toMH5N, L20of
MH5C was found to be distal from the N-terminal residue, I1, of the peptide with no evi-
dence of H-bonding between these two residues (9.95 Å, D).primarily responsible for membrane penetration by maximin H5 and
adopted a lipid interactive, hairpin-type conformation whose bilayer
partitioning was stabilised by a variety of lipid–peptide and intra pep-
tide bonds (Figs. 4A, B, 6 and 7A). The net negative charge carried by
maximin H5 results from an internal cluster of D residues, which were
distal from the membrane surface and appeared to play no direct role
in the membrane interactions of the peptide (Figs. 4B and 7A). Similar
observations have previously been reported and it has been suggested
that these residues primarily serve a structural role [39]. The
C-terminal amide group of maximin H5, L(NH2), hydrogen bonded to
the N-terminal residue of the peptide, I1, which terminated the major
arm of the hairpin structure adopted by maximin H5 (Fig. 7A and C).
Formed by residues, I1–S10, this sequence adopted an α-helical struc-
ture, which induced deep insertion of native maximin H5 into mem-
branes at an angle of circa 40° (Figs. 4B, 5C and 7A). It has previously
been shown that residues, I1–S10 form a tilted peptide [46,47], which
is anα-helixwith an increasingly asymmetric distribution of hydropho-
bicity along the α-helical long axis that induces membrane penetration
at a shallow angle between 30° and 60° [48,49]. However, our investiga-
tions also showed that the C-terminal deamination of maximin H5
removed the ability of its I1 and L20 residues to hydrogen bond
with each other and caused these residues tomove apart from a separa-
tion of 4.5 Å to 9.95 Å (Fig. 7), These actions led to lower levels of
N-terminal tilted structure in the peptide and a decreased ability to pen-
etrate membranes (Figs. 4B, 5D and 7B). Taken in combination, these
observations clearly suggest that a major function of the C-terminal
amide group of maximin H5 is to stabilise the levels of membrane inter-
active, oblique orientated α-helical structure adopted by the peptide in
its haemolytic activity. These observations would also seem to suggest
that hydrophobicity driven interactions make a major contribution to
the ability of native maximin H5 to penetrate membranes and in this
sense, although anionic, the peptide resembles many cationic AMPs
[46,47].
In summary, the data presented here suggest that the haemolytic
ability of native maximin H5 may render it a poor candidate for thera-
peutic development. For example, the level of haemolysis was 20% at
concentrations of the peptide required to inactivate S. aureus (Fig. 1).
However, when maximin H5 was C-terminally deaminated, although
the toxicity of the peptide to the latter organism was reduced, its
range of target bacteria was broadened. Also its haemolytic activity
were signiﬁcantly decreased, typically 12% at concentrations of the pep-
tide found to inactivate both S. aureus and E. coli (Fig. 1). Consistentwith
previous reports [50], these data show that the antimicrobial efﬁcacy
and speciﬁcity of maximin H5 can be attenuated by sequence modiﬁca-
tion and may assist in the development of variants of the peptide with
the potential to serve as anti-infectives. The data presented here also
suggests that the C-terminal amide moiety may play a role in the anti-
microbial and cytotoxic activity of maximin H5 by the stabilisation of
membrane interactive, tilted peptide structure. Indeed, the data pre-
sented here conﬁrm recent theoretical predictions for maximin H5
[46,47] and add it to the growingnumber of AMPs that utilise tilted pep-
tide structure to facilitate their membrane interactions [3].
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